-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ibutamoren Mesylate in Non Alcoholic Fatty Liver Disease (NAFLD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ibutamoren Mesylate in Non Alcoholic Fatty Liver Disease (NAFLD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ibutamoren Mesylate in Non Alcoholic Fatty Liver...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ucenprubart in Autoimmune Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ucenprubart in Autoimmune Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ucenprubart in Autoimmune Disorders Drug Details: Ucenprubart (LY-3454738) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Somapacitan LA in Born Small For Gestational Age (SGA)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Somapacitan LA in Born Small For Gestational Age (SGA) Drug Details: Somapacitan (Sogroya) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Somapacitan LA in Noonan Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Somapacitan LA in Noonan Syndrome Drug Details: Somapacitan (Sogroya) is a human growth hormone analog....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – YPEG-Somatropin in Idiopathic Short Stature
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.YPEG-Somatropin in Idiopathic Short Stature Drug Details:YPEG-somatropin is under development for the treatment of growth hormone...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Somapacitan La in Idiopathic Short Stature
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Somapacitan La in Idiopathic Short Stature report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Somapacitan LA in Idiopathic Short Stature Drug Details:Somapacitan (Sogroya) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Somapacitan LA in Turner Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Somapacitan LA in Turner Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Somapacitan LA in Turner SyndromeDrug Details:Somapacitan (Sogroya) is a human growth hormone...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Somatropin Pegol LA in Growth Hormone Deficiency
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Somatropin Pegol LA in Growth Hormone Deficiency report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Somatropin Pegol LA in Growth Hormone Deficiency Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lonapegsomatropin La in Turner Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lonapegsomatropin La in Turner Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Lonapegsomatropin La in Turner SyndromeDrug Details:Lonapegsomatropin (Skytrofa) is a long acting prodrug...
-
Product Insights
Turner Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Turner Syndrome Clinical Trials Overview The Turner Syndrome clinical trial report consists of 86 trials. The report provides an overview of the Turner Syndrome clinical trials scenario. The report provides top-line data relating to the clinical trials on Turner Syndrome. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and...